A detailed history of Wellington Shields & Co., LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 1,800 shares of NVO stock, worth $183,132. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,800
Previous 1,500 20.0%
Holding current value
$183,132
Previous $214,000 -0.0%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $35,721 - $43,625
300 Added 20.0%
1,800 $214,000
Q2 2024

Aug 07, 2024

BUY
$122.71 - $146.91 $49,084 - $58,764
400 Added 36.36%
1,500 $214,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $100,034 - $219,494
1,100 New
1,100 $100,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $66,170 - $79,570
500 New
500 $79,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wellington Shields & Co., LLC Portfolio

Follow Wellington Shields & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.